SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-211544
Filing Date
2013-05-10
Accepted
2013-05-09 17:47:01
Documents
13
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d508528d10q.htm 10-Q 625610
2 EX-10.68.2 d508528dex10682.htm EX-10.68.2 32676
3 EX-10.83.1 d508528dex10831.htm EX-10.83.1 25745
4 EX-31.1 d508528dex311.htm EX-31.1 10304
5 EX-31.2 d508528dex312.htm EX-31.2 10503
6 EX-32.1 d508528dex321.htm EX-32.1 4003
7 EX-32.2 d508528dex322.htm EX-32.2 4253
  Complete submission text file 0001193125-13-211544.txt   4869299

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT slxp-20130331.xml EX-101.INS 621339
9 XBRL TAXONOMY EXTENSION SCHEMA slxp-20130331.xsd EX-101.SCH 53030
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE slxp-20130331_cal.xml EX-101.CAL 57808
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE slxp-20130331_def.xml EX-101.DEF 152255
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE slxp-20130331_lab.xml EX-101.LAB 403122
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE slxp-20130331_pre.xml EX-101.PRE 262038
Mailing Address 8510 COLONNADE CENTER DRIVE RALEIGH NC 27615
Business Address 8510 COLONNADE CENTER DRIVE RALEIGH NC 27615 (919) 862-1000
SALIX PHARMACEUTICALS LTD (Filer) CIK: 0001009356 (see all company filings)

IRS No.: 943267443 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23265 | Film No.: 13830339
SIC: 2834 Pharmaceutical Preparations